Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pluvicto
Pharma
Proposed nuclear rules threaten Novartis’ Pluvicto
Experts warn that a draft guide by nuclear authorities contains rigid assumptions that could add barriers to patient access to radiopharmaceuticals.
Angus Liu
Oct 6, 2026 9:00am
Novartis' Pluvicto unlocks substantial new patient pool
Aug 3, 2026 8:33am
Novartis stands by $5B Pluvicto goal despite EU regulatory setback
Apr 28, 2026 10:10am
With EU backing, Sanofi gains long-awaited win for tolebrutinib
Apr 24, 2026 11:30am
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
Novartis details plan for 2nd new US radiopharma plant
Feb 25, 2026 9:55am
